Redefining the Business of Blood
Maximizing the Value of Whole Blood Donations Worldwide
Blood collection facilities are faced with how to collect, process and deliver the highest quality blood products utilizing the safest, quickest and most efficient processes, while eliminating waste. Blood collection systems must be designed to meet these challenges by helping to:
- Streamline Processes and give you FLEXIBILITY in processing with rapid filtration times under all processing conditions.
- Eliminate Waste and give you improved EFFICIENCY over dockable systems.
- Deliver High Quality Blood Products and give you RELIABILITY in your process that exceeds industry standards and guidelines.
- Improve Product Availability & the Bottom-Line and give you better PROFITABILITY from manual WB collections.
We realize there is no one generic solution to address the many issues that challenge the smooth flow of a blood center and hospital operation and their financial viability. Pall Medical is committed to providing its expertise to help you maximize your business potential. So, take the opportunity to see how Pall Medical is continuing the tradition of providing a portfolio of products with innovative technologies that are designed to support your strategic objectives for reduced costs, improved profits and product availability:
- Today's Healthcare Environment
- What does 'Redefining the Business of Blood' mean?
- Taking the First Step
- Maximizing the Value of Whole Blood Donations
- Reviewing Your Options - Leukoreduced BBCs with a . . .
Today's Healthcare Environment
New discoveries, new technologies, therapeutic changes, new protocols, medical advances and stricter regulations constantly dictate the necessity to change. The world of supply is without exception. It too, must stay at the pinnacle of quality care and maintain economic viability while confronted with:
- Increasing demand for high quality components to support therapeutic innovation.
- Higher costs of implementing a safer blood supply.
- Growing requirements for quality and safety measures among customers.
- Emerging global infectious threats to our blood supply.
- Stricter regulatory requirements for the manufacturing of blood products.
- Labor and logistical implications of providing products to an ever increasing number of patients, despite a shrinking donor pool.
Facing these challenges, blood centers must make smarter decisions to maximize their business potential and at the same time enhance their ability to provide the highest quality blood transfusion product.
What does 'Redefining the Business of Blood' mean?
Redefining the Business of Blood means taking a fresh look at your operations to pinpoint the "high-return" areas to invest your time, finances and resources to improve operations. You will then have the valuable insight into where revenue income can be generated and where areas of profitability can be improved. Pall Medical is committed to providing its expertise to help you optimize your business potential every step of the way.
Taking the First Step
Business optimization starts with knowing where your center is headed and understanding the challenges you will face in getting there. When you look at your overall business, what are the issues that concern you most?
- Is importing product an issue for your center? In what ways?
- Do you have an opportunity to export product? If so, could this be an important part of your business?
- Are there competitors moving into the area? Who are your main competitors? In what ways have they affected your business?
Are you competing primarily for more donors or for more customers? - Is expanding your center's business and customer base a major concern?
- Are you concerned about collection issues such as recruitment, staffing, processing, and so on?
- How frequently do you talk to your customers about issues that concern them? What plans do you have to change the products you offer to help meet your customers' needs?
- How does the need to leukoreduce product affect your center's planning, if at all, such as collections space and staffing, lab space and staffing, inventory, etc.?
Maximizing the Value of Whole Blood Donations
Over fourteen million units of whole blood are collected in the United States each year from an ever shrinking pool of eligible donors. Whole blood is such a valuable resource that it needs to be maximized to its fullest potential. A blood collection facility that approaches whole blood donation with this in mind, has the greatest potential to redefine their blood business to achieve their goals and satisfy their customers' needs.
- Plasma...a resource in high demand. After a period of market fluctuations in the value of plasma earmarked for further manufacturing, the demand for plasma is on the rise.
- Whole blood (WB)-derived platelets...an untapped resource. Based on a 2005 survey, platelet concentrates were prepared from only 30.3% of whole blood donations1. Though single-donor platelets made up the difference in platelet transfusion needs, the margin between supply and demand is small.
1 Whitaker Bl, Sullivan M (Ed.). (2005). In the 2005 Nationwide Blood Collection and Utilization Survey Report. Rockville, MD: US Dept. of Health & Human Services
Reviewing Your Options - Leukoreduced RBCs with a...
Maximizing plasma yields and increasing platelet availability through WB donations gives your facility the ability to adequately supply leukoreduced RBCs (red blood cells) and address:
- Supply issues due to donor restrictions related to TRALI (Transfusion Related Acute Lung Injury).
- High operational costs driven by market economics and regulatory requirements.
As you can see in the table below, all WB and RBC filtration systems can help you achieve your plasma needs. Choosing the appropriate system depends on tradeoffs between plasma yields and workflow efficiency. Only an RBC or RBC/PLT (red blood cell/platelet) in-line filtration system coupled with a platelet pooling system truly maximizes product yields from WB donations. The path you take to achieve business optimization is unique to your facility.
Click on the Category headings to learn more about your options.
Click on the System names to learn more how these products can help you achieve your goals.
| Category A Focus on Plasma ONLY Workflow Considerations |
Category B Focus on Plasma and LR WB-derived Platelets Improving Product Yields |
Category C Focus on LR WB-derived Platelets ONLY Improving Safety and Availability |
|
| Option 1 | Leukotrap RC System with RCD2 Filter |
Leukotrap RC with RC2D Filter with Acrodose Plus Systems |
Leukotrap RC PL and Acrodose PL Systems |
| Option 2 | Leukotrap WB with SAVE System |
Leukotrap SC RC with Acrodose Plus Systems and Standard Collection Bag |
Leukotrap PL and Acrodose PL Systems with Leukotrap SC RC System |
| Option 3 | Leukotrap SC RC System | Leukotrap RC with RC2D Filter with Acrodose Plus Systems |
|
| Option 4 | Leukotrap SC RC with Acrodose Plus Systems and Standard Collection Bag |
||
Product Specification Sheets for:
WB In-Line Systems- RBC In-Line Systems
- RBC Dockable Systems
- Platelet In-Line Systems
- Platelet Pool & Store Systems
- Platelet Bacteria Detection Systems
- Blood Collection Sets